Genome sequencing of all positive samples in Maha, don't panic: official

Maharashtra's state surveillance officer said all swab Covid positive samples will be sent for genome sequencing to track any new variant

Genome, sample
Press Trust of India Pune
2 min read Last Updated : Dec 21 2022 | 11:11 PM IST

Don't want to miss the best from Business Standard?

Maharashtra's state surveillance officer on Wednesday said all swab samples testing positive for COVID-19 will be sent for genome sequencing to track any new variant and maintained there was no need to panic in view of the current surge in cases in China, said to be driven by a new strain of Omicron.

State surveillance officer Dr Pradip Awate's statement came a day after the Centre asked states to step up genome sequencing of positive swab samples amid a spurt in coronavirus cases in the US, China and some other countries. Awate said they are already conducting genome sequencing of samples, but since the number of positive cases has come down in the last few months, the sequencing process, too, has slowed down. Genome sequencing is a laboratory test that can map out the whole genetic makeup of a virus from a patient's swab sample. "Earlier, we used to pick up samples of serious patients, admitted patients, patients who had re-infection after vaccination, and patients from particular clusters for genome sequencing. But as per the Centre's guidelines, we will be sending all the RT-PCR positive samples for genomic sequencing now," he told PTI here. Awate, however, said there was no need to hit the panic button and pointed out that three cases of the Omicron subvariant BF.7, apparently the strain driving China's current COVID-19 surge, have been already detected in India (two in Gujarat and one in Odisha). He said BF.7, the sub-lineage of BA.5, has already been detected in India, but it did not spread among the country's population. "At the same time, the BQ.1 sub-variant, which has been found in the United States of America, was also found in India and Maharashtra and that also did not lead to a spurt in cases," said the surveillance officer. Awate said since all these variants have already been spotted in India, there was a slim possibility of anything going wrong, "so no need to press the panic button". Maharashtra's coordinator for genome sequencing Dr Rajesh Karyakarte said they are geared up for the process to detect any new variant. So far, the XBB sub-variant has been the dominant strain of coronavirus in Maharashtra, accounting for more than 70 per cent of the positive cases, he said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusMaharashtrahealth news

First Published: Dec 21 2022 | 11:11 PM IST

Next Story